<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Physiology and Pharmacology</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C7018E93-1A33-46A1-8A52-B9D6172469A8"><gtr:id>C7018E93-1A33-46A1-8A52-B9D6172469A8</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Lythgoe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/06AE1AB5-19CE-44C1-A0AC-6B79EA4E75CD"><gtr:id>06AE1AB5-19CE-44C1-A0AC-6B79EA4E75CD</gtr:id><gtr:firstName>Sergey</gtr:firstName><gtr:surname>Kasparov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9F79BB8E-0507-40B5-83FC-1E29D5BE7141"><gtr:id>9F79BB8E-0507-40B5-83FC-1E29D5BE7141</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:surname>Gourine</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ013110%2F1"><gtr:id>9703790F-FB60-4596-AA50-04C8F1698A49</gtr:id><gtr:title>Dissection of the cellular mechanisms of functional MRI using targeted optogenetics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J013110/1</gtr:grantReference><gtr:abstractText>Magnetic resonance imaging (MRI) is perhaps the biggest advancement in human imaging technology since
the discovery of X-rays by Roentgen. Initially it was used to provide structural information about the body
and the brain but it was the introduction of functional MRI (fMRI) that had the most profound impact on
neuroscience and basic cognitive research. Although fMRI is widely used in clinical and experimental
neurology, the fundamental cellular mechanism of fMRI remains poorly understood. This limits the value of
the information generated by this exciting technology. Brain is a highly complex organ and signals measured
by fMRI are indirect and although they do reflect activation and de-activation of nerve cells in various parts
of the brain. This research will look at the cellular basis of fMRI using a new technology called
&amp;quot;optogenetics&amp;quot; voted &amp;quot;Method of year 2010&amp;quot;. Optogenetics allows us to make certain cells light sensitive,
such that we can switch them 'on' and 'off' using light. Quite simple we will be able to control the brain
via light and watch this happen in real time using the MRI scanner. Our results should not only shine a light
on how fMRI works, but also have wider implications for human brain research.</gtr:abstractText><gtr:technicalSummary>Functional MRI (fMRI) has made a dramatic impact on clinical neurology and basic research but the cellular basis of haemodynamic responses underlying BOLD signals remain elusive. Understanding the origins of BOLD signal is essential to make connections between basic and clinical neuroscience. BOLD signals reflect changes in blood flow, volume and the rate of O2 consumption. They are underpinned by the &amp;quot;functional hyperemia&amp;quot; which couples delivery of oxygenated blood to neuronal activity. The emerging consensus is that the reactive hyperemia is not a compensatory response to depletion of O2 but a feed-forward phenomenon. The link between neuronal activity and brain microcirculation is indirect. Recent evidence strongly implicates astrocytes in neurovascular coupling. However, much of the current knowledge comes from in vitro slice work and the role of astrocytes in neurovascular coupling and generation of BOLD signals remains poorly understood. We propose to use optogenetics to study the cellular mechanisms of fMRI and focus on astrocytes. Optogenetics permits targeted manipulation of the specified cell populations using light sensitive proteins. We were first to apply optogenetics to study astrocytes (Science, 2010, 329, 571-5) and are in an excellent position to study role of astroglia neurovascular coupling and fMRI. Astrocytes and neurones will be made to express various optogenetic tools to enable us to monitor the impact of their selective activation or deactivation on cortical microcirculation and this will be paralleled with fMRI at 9.4T. Signalling molecules essential for neurone-to astrocyte-to blood vessels signalling will be identified using genetic and pharmacological tools. Optogenetic activation of neuronal projections and natural stimuli will be applied in order to reveal how compromised astrocitic signalling changes vascular responses and BOLD signals. Our hypothesis is that astrocytes are fundamentally important for generation of BOLD signals.</gtr:technicalSummary><gtr:potentialImpactText>fMRI has the most profound impact on neuroscience and basic cognitive research but its fundamental cellular mechanism remains poorly understood. This limits the value of the information generated by this exciting technology. This project aims to investigate the fundamental mechanisms of neurovascular coupling between neurones, astrocytes and blood vessels. It is expected to reveal fundamental mechanisms of brain function and therefore, the basic science value of these studies is very high. Basic neuroscientists or clinical researchers may certainly benefit from the proposed work. The results will be available to a wider scientific community via publication in the leading scientific journals. 
We will also seek to improve the public perception of the value and role of the functional imaging and optogenetics. Both UoB and UCL provide public engagement mechanisms for ensure accurate representation to foster public support. We hope to generate some high profile papers which could be a good opportunity to generate press releases and give presentations to general public. Our recent publication in SCIENCE has attracted world-wide comments in media ranging from &amp;quot;Spiegel&amp;quot; and &amp;quot;Discover&amp;quot; magazines to various neuroscience blogs. ML is Director of the Cheltenham Science Festival, one of the largest science communication festivals in the world which provides great potential to engage with national communities about this work. In addition, this project includes numerous imaging experiments which sometimes generate very visually appealing images. Images from the SK laboratory have been used by the Physiological society, Royal Society, Wellcome trust, Experimental Physiology for generation of leaflets and brochures, this directly communicates the appeal of science to general public. 
Capacity building. Wider physiological and pharmacological research communities, both in academia and pharmaceutical industry, would benefit from the wider introduction of optogenetics, which is at the heart of this proposal. Training personnel with skills in fMRI is clearly also a priority and will be essential to support wider implementation of this powerful technology. As indicated in the MRC feedback letter, building capability in optogenetics is of strategic importance to the UK science base.This project provides an excellent platform for training or personnel (PhD students and PostDocs) and dissemination of optogenetics in the UK.
Engagement and Communications. We actively engage the community in science and research we undertake by increasing public understanding of our discipline. UCL Media Relations provides excellent opportunities to engage with local and national communities. We will access existing UCL public engagement mechanisms to ensure accurate representation to foster public support. 
Translational potential: In a longer term, our research may directly contribute to the improvement of human health. If we better understand how BOLD signals are generated this will have implications to the interpretation of the changes seen in patients, possibly help to improve diagnostics and interpret the results of treatments. It is also possible that the basic research into the mechanism of neurovascular coupling may offer new drug targets for treatment of brain disorders many of which are accompanied by changes in microcirculation. These drugs may prove to be effective in reducing morbidity and improving quality of life of patients with various neurologic diseases. We are in direct contact with the clinicians involved in human fMRI, who also sit on our advisory panel. This provides a direct conduit for clinical translation and will help to develop a strategy to analyze already available clinical fMRI datasets obtained in patients who were taking prescribed medications known to interfere with hypothesised signalling pathways.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>709590</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Uncovered event in British Museum</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>85332734-432B-4F7C-91BB-CAB46E0B78AA</gtr:id><gtr:impact>Over 100 visitors attended.

Many dialogues explaining the value of bioimaging and basic research</gtr:impact><gtr:outcomeId>enwusmdjwdC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>628A90F0-23EF-499F-8C9E-CBF97EF699D4</gtr:id><gtr:title>Investigating Spatial Correlations of Neurovascular Coupling using Opto-fMRI</gtr:title><gtr:parentPublicationTitle>Scientific Reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b78ba8bbc11ce939893efe4791879977"><gtr:id>b78ba8bbc11ce939893efe4791879977</gtr:id><gtr:otherNames>Christie I.N.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5460afce2751c6.48446314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6993DA3D-5B94-485A-B1D1-1350737990C2</gtr:id><gtr:title>Are Astrocytes the Pressure-Reservoirs of Lactate in the Brain?</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb029c53b496c5cfcede5d2368d412d0"><gtr:id>eb029c53b496c5cfcede5d2368d412d0</gtr:id><gtr:otherNames>Kasparov S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>56c737e12be3e6.02495538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F673EF88-CC3D-408D-A422-BFB73F134CE5</gtr:id><gtr:title>Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/560e9184abefaf3ac57104dfe356a93e"><gtr:id>560e9184abefaf3ac57104dfe356a93e</gtr:id><gtr:otherNames>O'Callaghan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a2fd75e3d2df1.34306887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68D5EF9A-BD2C-47A8-BA38-8D08F428D96B</gtr:id><gtr:title>Quantification of light attenuation in optically cleared mouse brains.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical optics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75dd0fdf9c88164316c19e954b495d6d"><gtr:id>75dd0fdf9c88164316c19e954b495d6d</gtr:id><gtr:otherNames>d'Esposito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1083-3668</gtr:issn><gtr:outcomeId>5a324e54e44f39.55300547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBBF088C-F720-49C2-83C7-9806A2D88783</gtr:id><gtr:title>A critical role for purinergic signalling in the mechanisms underlying generation of BOLD fMRI responses.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/910416dfe1e1fa70a891474bbc9375d7"><gtr:id>910416dfe1e1fa70a891474bbc9375d7</gtr:id><gtr:otherNames>Wells JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>56210b9adbf726.75108131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8E07071-199A-4015-AF8A-48C3496D3B63</gtr:id><gtr:title>Is your system calibrated? MRI gradient system calibration for pre-clinical, high-resolution imaging.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/560e9184abefaf3ac57104dfe356a93e"><gtr:id>560e9184abefaf3ac57104dfe356a93e</gtr:id><gtr:otherNames>O'Callaghan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e194e194e2f95e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A03017C-E82E-4A83-8B34-8325F3081C03</gtr:id><gtr:title>Characterising the fMRI signal response to direct light delivery in naive rats: implication for the design and interpretatino of opto-fMRI studies</gtr:title><gtr:parentPublicationTitle>SFN proceedings</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>kBEWv1oKJfs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A402B6AE-3A86-4947-8FFF-E5CD335C90C2</gtr:id><gtr:title>Volumetric Spatial Correlations of Neurovascular Coupling Studied using Single Pulse Opto-fMRI.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c6bb5498ac83.30747454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9D639EE-62DF-4A3E-B29F-24C502E17C9C</gtr:id><gtr:title>Flow-Based Single Cell Deposition for High-Throughput Screening of Protein Libraries.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8c2649c4e18ff622e1b01d11ab049ce"><gtr:id>f8c2649c4e18ff622e1b01d11ab049ce</gtr:id><gtr:otherNames>Stowe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a324db2658c66.37303712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>098B9B74-3806-4A6A-9FAC-C3ECB6BA29D2</gtr:id><gtr:title>Decomposition of spontaneous fluctuations in tumour oxygenation using BOLD MRI and independent component analysis.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec25808315399ea0591f77d4c3a4f6e6"><gtr:id>ec25808315399ea0591f77d4c3a4f6e6</gtr:id><gtr:otherNames>Gon?alves MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5a324ead485769.38029096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EF0856E-146E-43EF-BE06-4845E377E501</gtr:id><gtr:title>Comparative analysis of optogenetic actuators in cultured astrocytes.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8671360143aa021f92db8c66abb36b2b"><gtr:id>8671360143aa021f92db8c66abb36b2b</gtr:id><gtr:otherNames>Figueiredo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn><gtr:outcomeId>doi_55f986986525e095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>697946D6-F0AF-4D86-93B5-A6E2FC462D17</gtr:id><gtr:title>Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1992cc9a6757f022ae884f1669c587aa"><gtr:id>1992cc9a6757f022ae884f1669c587aa</gtr:id><gtr:otherNames>Johnson SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5a32488121c630.72004076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A4E385-4E97-46C6-8747-70B6A137C62B</gtr:id><gtr:title>In amnio MRI of mouse embryos.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b5b9896c512571388456fd43098b240"><gtr:id>3b5b9896c512571388456fd43098b240</gtr:id><gtr:otherNames>Roberts TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a3256492e5be7.70092799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE2A303-8141-4708-9D7C-DB1A1C55CF4C</gtr:id><gtr:title>fMRI response to blue light delivery in the na&amp;iuml;ve brain: implications for combined optogenetic fMRI studies.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>sfX1NX2nrPE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>015C67A5-C138-4728-AF84-93F370DF501E</gtr:id><gtr:title>Comparison ofandMRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/248324647375bbbdfbd7c9cc13697946"><gtr:id>248324647375bbbdfbd7c9cc13697946</gtr:id><gtr:otherNames>Holmes HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5196</gtr:issn><gtr:outcomeId>5a35e5d1155df2.47262393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>661C2CDF-42EA-4BF3-B0ED-7AF3D8D5A56D</gtr:id><gtr:title>Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38926ea3ac0bbc1dd4d07f0ca56e7f93"><gtr:id>38926ea3ac0bbc1dd4d07f0ca56e7f93</gtr:id><gtr:otherNames>Muthana M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a324fef14cc70.88022395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E260F379-38CD-4A78-9B96-8AC066E2409E</gtr:id><gtr:title>Ultrastructural Correlates of Enhanced Norepinephrine and Neuropeptide Y Cotransmission in the Spontaneously Hypertensive Rat Brain.</gtr:title><gtr:parentPublicationTitle>ASN neuro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe1e4a84dde83851353c0dabd1fe70b5"><gtr:id>fe1e4a84dde83851353c0dabd1fe70b5</gtr:id><gtr:otherNames>Kourtesis I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-0914</gtr:issn><gtr:outcomeId>56c738088019a1.42635204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F05A61C-FE5B-4A61-9F15-F96E68EEBF03</gtr:id><gtr:title>Lactate-mediated glia-neuronal signalling in the mammalian brain.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a232e0a3660b49b0d8b24aa6e95f94f"><gtr:id>3a232e0a3660b49b0d8b24aa6e95f94f</gtr:id><gtr:otherNames>Tang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_540e194e194d3a679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>056B0232-7B9D-4B85-8C10-7985A530E76B</gtr:id><gtr:title>Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bc612aee1a041cd83e7548e096aec77"><gtr:id>8bc612aee1a041cd83e7548e096aec77</gtr:id><gtr:otherNames>Connell JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>5a324cb0185877.24367272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60EC1CFC-D3F7-448B-A410-2A6D811B49CB</gtr:id><gtr:title>Direct comparison of high-temporal-resolution CINE MRI with Doppler ultrasound for assessment of diastolic dysfunction in mice.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b5b9896c512571388456fd43098b240"><gtr:id>3b5b9896c512571388456fd43098b240</gtr:id><gtr:otherNames>Roberts TA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>5a2fd379f0f264.68782610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88FA5262-CF47-49B5-BF97-078ADB4AD7C4</gtr:id><gtr:title>Fully-Automated ?MRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f7821d45e197968a2159d1c9be04b69"><gtr:id>8f7821d45e197968a2159d1c9be04b69</gtr:id><gtr:otherNames>Powell NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a35e724834ad8.56749241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C69C699-3E18-46B6-8343-522747D54A01</gtr:id><gtr:title>Characterising the fMRI signal response to direct light delivery in naive rats: implication for the design and interpretatino of opto-fMRI studies</gtr:title><gtr:parentPublicationTitle>ISMRM British Chapter 2012</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>qU79nphV2bK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C94F275A-FB55-4C78-8370-827545C28140</gtr:id><gtr:title>fMRI mapping of the visual system in the mouse brain with interleaved snapshot GE-EPI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d664ad9f3890779d9a129fde93dbc54b"><gtr:id>d664ad9f3890779d9a129fde93dbc54b</gtr:id><gtr:otherNames>Niranjan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>58c9256d04ef81.49816063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5375C13D-3D5B-4BF4-81A7-86954DF80713</gtr:id><gtr:title>Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/910416dfe1e1fa70a891474bbc9375d7"><gtr:id>910416dfe1e1fa70a891474bbc9375d7</gtr:id><gtr:otherNames>Wells JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>5a360cabbadef8.15580877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5B0E45D-8A56-4668-BEA9-DD4629EDEA1F</gtr:id><gtr:title>A critical role for purinergic signalling in the mechanisms underlying generation of BOLD fMRI responses.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/910416dfe1e1fa70a891474bbc9375d7"><gtr:id>910416dfe1e1fa70a891474bbc9375d7</gtr:id><gtr:otherNames>Wells JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>5460af5e80a4a7.01898012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D6BE0A0-A128-4C88-A204-5F36F38341DC</gtr:id><gtr:title>Diffusion microscopic MRI of the mouse embryo: Protocol and practical implementation in the splotch mouse model.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a00df7835064f5c8e459f8775608b485"><gtr:id>a00df7835064f5c8e459f8775608b485</gtr:id><gtr:otherNames>Norris FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>5a3503aea62823.82189342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>072E2CC1-AE2B-4138-9E88-1854F4D19F29</gtr:id><gtr:title>Hepatic arterial spin labelling MRI: an initial evaluation in mice.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff3144312ff07b6ae140f7956468a077"><gtr:id>ff3144312ff07b6ae140f7956468a077</gtr:id><gtr:otherNames>Ramasawmy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>5a2fd23bb41cd9.23961657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>926698FE-E11D-41D0-887B-D9A6BE446BCE</gtr:id><gtr:title>A novel molecular tool to investigate ATP signalling</gtr:title><gtr:parentPublicationTitle>Gordon Research Conference presentation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>ePyKq1zTLf6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4DC9EC3-DFC8-445E-B62C-FDCA365BA9C2</gtr:id><gtr:title>Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35eafa1d8a87964f26ae595777bead68"><gtr:id>35eafa1d8a87964f26ae595777bead68</gtr:id><gtr:otherNames>Colgan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a2fd41f444d58.35886671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22E3B5EC-B5AC-4B0D-9483-08596953A1D5</gtr:id><gtr:title>In vivo imaging of tau pathology using multi-parametric quantitative MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/910416dfe1e1fa70a891474bbc9375d7"><gtr:id>910416dfe1e1fa70a891474bbc9375d7</gtr:id><gtr:otherNames>Wells JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a3254b49e43c8.43667328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>367C0D51-3C0C-440D-9B54-503516BF0077</gtr:id><gtr:title>ATP-mediated signaling plays key role in the generation of BOLD fMRI signal</gtr:title><gtr:parentPublicationTitle>ISMRM British Chapter 2013</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f107658d682701109ce77627a08a651"><gtr:id>8f107658d682701109ce77627a08a651</gtr:id><gtr:otherNames>Christie IN</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>XCrP9yJmt2s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61B8A006-C65B-4EB8-A3EF-CA76CF29FD0F</gtr:id><gtr:title>Bimodal Imaging of Inflammation with SPECT/CT and MRI Using Iodine-125 Labeled VCAM-1 Targeting Microparticle Conjugates.</gtr:title><gtr:parentPublicationTitle>Bioconjugate chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7e5c339c1607f10a4d6e1d2f0b85b6"><gtr:id>bb7e5c339c1607f10a4d6e1d2f0b85b6</gtr:id><gtr:otherNames>Patel N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1043-1802</gtr:issn><gtr:outcomeId>5a2fdb00375e46.96162332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB2C259C-80BC-4C25-A96B-E38E000E9847</gtr:id><gtr:title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/248324647375bbbdfbd7c9cc13697946"><gtr:id>248324647375bbbdfbd7c9cc13697946</gtr:id><gtr:otherNames>Holmes HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5a2fda707c8c78.01833842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B126E4F-2D19-4307-B3EC-C1D99459EC4B</gtr:id><gtr:title>Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff3144312ff07b6ae140f7956468a077"><gtr:id>ff3144312ff07b6ae140f7956468a077</gtr:id><gtr:otherNames>Ramasawmy R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fd5fb531e89.12523713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E1442C3-C512-43D5-9695-8D61A23246FD</gtr:id><gtr:title>The effect of imatinib therapy on tumour cycling hypoxia, tissue oxygenation and vascular reactivity</gtr:title><gtr:parentPublicationTitle>Wellcome Open Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e2292f6ad6a85b4b53e0b3b8138b08b"><gtr:id>1e2292f6ad6a85b4b53e0b3b8138b08b</gtr:id><gtr:otherNames>Gon?alves M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd34c3319b8.88965824</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J013110/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>